Higher tariffs on pharma products in the US may lead to increased prices and reduced demand.The impact on the Indian pharma industry will depend on the trade depletion and trade diversion effects.The low substitutability between Indian generic drugs and expensive patented drugs reduces the trade diversion effect for Indian pharma industry.The demand for Indian pharma exports in the US is relatively inelastic, so any tariff-led price increase is likely to be absorbed by US consumers.